ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Vice President, Patient Operations at Beam Therapeutics - ApplyBlast

Vice President, Patient Operations

Beam Therapeutics

21 days ago

4.1 on Glassdoor

Cambridge, Massachusetts, United States

Hybrid

Full Time

Executive

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Beam Therapeutics is seeking a strategic leader to shape and oversee patient scheduling and apheresis operations for its gene therapy programs, including the upcoming commercialization of risto-cel. This role involves implementing a cell therapy orchestration platform, building operational teams, and defining strategies for patient supply and provider experience. The position requires cross-functional collaboration to ensure scalable processes and an exceptional treatment experience for patients and providers.

Responsibilities

Define strategy for patient scheduling and apheresis operations
Lead implementation of cell therapy orchestration platform
Partner with cross-functional teams to ensure scalable processes

Skills

Qualifications

BSBAMBAMDPhD

About Beam Therapeutics

beamtx.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

501-1000 employees

Founded

2017

View Profile

Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.